封面
市场调查报告书
商品编码
1386121

猫疫苗市场报告:2030 年趋势、预测与竞争分析

Cat Vaccine Market Report: Trends, Forecast and Competitive Analysis to 2030

出版日期: | 出版商: Lucintel | 英文 150 Pages | 商品交期: 3个工作天内

价格

本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

猫疫苗趋势和预测

预计到 2030 年,全球猫疫苗市场将达到 17 亿美元,2024 年至 2030 年复合年增长率为 7.2%。这个市场的主要驱动因素是养猫数量的增加以及对预防猫传染病的疫苗接种的强烈需求。全球猫疫苗市场前景广阔,兽医院、宠物店、线上零售通路蕴藏商机。

猫疫苗市场洞察

Lucintel 预测,减毒活病毒疫苗将继续成为最大的细分市场,因为它们效率高,并且能够支持抗体和细胞介导的免疫反应。

在这个市场中,预计兽医院将在预测期内实现最高成长。

由于政府对保护猫免受严重疾病的疫苗接种的严格规定以及美国猫拥有量的增加,北美将继续成为最大的地区。

市场规模/估计:以金额的猫疫苗市场规模估计(10 亿美元)。

趋势和预测分析:各个细分市场和地区的市场趋势(2018-2023)和预测(2024-2030)。

細項分析:按技术、年龄、配销通路和地区分類的猫疫苗市场规模(十亿美元)。

区域分析:北美、欧洲、亚太地区和世界其他地区的猫疫苗市场细分。

成长机会:按技术、年龄、配销通路和地区对猫疫苗市场进行成长机会分析。

策略分析:猫疫苗市场併购、新产品开发、竞争形势等。

基于波特五力模型的产业竞争实力分析。

本报告回答了 11 个关键问题:

  • Q.1. 细分市场中最有前途和高成长的机会是什么?
  • Q.2.哪个细分市场将以更快的速度成长?为什么?
  • Q.3.您认为哪些地区未来会出现更快的成长?为什么?
  • Q.4. 影响市场动态的主要因素有哪些?市场的主要挑战和商业风险是什么?
  • Q.5. 这个市场的商业风险和竞争威胁是什么?
  • Q.6.这个市场有哪些新趋势?为什么?
  • Q.7.市场客户需求有何改变?
  • Q.8. 该市场有哪些新发展以及哪些公司处于领先地位?
  • Q.9.这个市场的主要企业有哪些?主要企业采取哪些策略配合措施来发展业务?
  • Q.10. 该市场上的竞争产品有哪些?由于材料或产品替代而导致市场占有率下降的威胁有多大?
  • Q.11.过去五年发生了哪些併购事件,对产业产生了哪些影响?

目录

第一章执行摘要

第二章全球猫疫苗市场:市场动态

  • 简介、背景、分类
  • 供应链
  • 产业驱动因素与挑战

第三章 2018-2030年市场趋势及预测分析

  • 宏观经济趋势(2018-2023)与预测(2024-2030)
  • 全球猫疫苗市场趋势(2018-2023)与预测(2024-2030)
  • 按技术分類的全球猫疫苗市场
    • 减毒活病毒疫苗
    • 结合疫苗
    • 灭活疫苗
    • 次单位疫苗
    • 类毒素疫苗
    • DNA疫苗
    • 重组疫苗
  • 按年龄分類的全球猫疫苗市场
    • 少于6个月
    • 6个月或以上
  • 按配销通路分類的全球猫疫苗市场
    • 动物医院
    • 宠物商店
    • 线上零售商

第四章 2018-2030年区域市场趋势及预测分析

  • 全球猫疫苗市场区域分布
  • 北美猫疫苗市场
  • 欧洲猫疫苗市场
  • 亚太猫疫苗市场
  • 其他地区猫疫苗市场

第五章竞争分析

  • 产品系列分析
  • 营运整合
  • 波特五力分析

第六章 成长机会与策略分析

  • 成长机会分析
    • 全球猫疫苗市场成长机会(按技术)
    • 按年龄分類的全球猫疫苗市场成长机会
    • 全球猫疫苗市场成长机会(按配销通路)
    • 全球猫疫苗市场成长机会(按地区)
  • 全球猫疫苗市场的新趋势
  • 战略分析
    • 新产品开发
    • 全球猫疫苗市场产能扩张
    • 全球猫疫苗市场的合併、收购与合资
    • 认证和许可

第七章主要企业概况

  • Elanco Animal Health
  • Boehringer Ingelheim
  • Merck
  • Zoetis
  • Bioveta
简介目录

Cat Vaccine Trends and Forecast

The future of the global cat vaccine market looks promising with opportunities in the veterinary clinic, pet store, and online retailer channels. The global cat vaccine market is expected to reach an estimated $1.7 billion by 2030 with a CAGR of 7.2% from 2024 to 2030. The major drivers for this market are rising cat ownership and significant demand for vaccinations to prevent cat-transmitted diseases.

A more than 150-page report is developed to help in your business decisions.

Cat Vaccine by Segment

The study includes a forecast for the global cat vaccine by technology, age, distribution channel, and region.

Cat Vaccine Market by Technology [Shipment Analysis by Value from 2018 to 2030]:

  • Attenuated Live Vaccines
  • Conjugate Vaccines
  • Inactivated Vaccines
  • Subunit Vaccines
  • Toxoid Vaccines
  • DNA Vaccines
  • Recombinant Vaccines

Cat Vaccine Market by Age [Shipment Analysis by Value from 2018 to 2030]:

  • Below 6 Months
  • Above 6 Months

Cat Vaccine Market by Distribution Channel [Shipment Analysis by Value from 2018 to 2030]:

  • Veterinary Clinics
  • Pet Stores
  • Online Retailers

Cat Vaccine Market by Region [Shipment Analysis by Value from 2018 to 2030]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

List of Cat Vaccine Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies cat vaccine companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the cat vaccine companies profiled in this report include-

  • Elanco Animal Health
  • Boehringer Ingelheim
  • Merck
  • Zoetis
  • Bioveta

Cat Vaccine Market Insights

Lucintel forecasts that attenuated live will remain the largest segment due to its high efficiency and helps for both antibody and cellular immune responses.

Within this market, veterinary clinics is expected to witness highest growth over the forecast period.

North America will remain the largest region due to strict government regulations regarding vaccination in protecting the cats from serious diseases and rising adoption of cats in the USA.

Features of the Global Cat Vaccine Market

Market Size Estimates: Cat vaccine market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Cat vaccine market size by technology, age, distribution channel, and region in terms of value ($B).

Regional Analysis: Cat vaccine market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different technologies, ages, distribution channels, and regions for the cat vaccine market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the cat vaccine market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q.1 What is the cat vaccine market size?

Answer: The global cat vaccine market is expected to reach an estimated $1.7 billion by 2030.

Q.2 What is the growth forecast for cat vaccine market?

Answer: The global cat vaccine market is expected to grow with a CAGR of 7.2% from 2024 to 2030.

Q.3 What are the major drivers influencing the growth of the cat vaccine market?

Answer: The major drivers for this market are rising cat ownership and significant demand for vaccinations to prevent cat-transmitted diseases.

Q4. What are the major segments for cat vaccine market?

Answer: The future of the cat vaccine market looks promising with opportunities in the veterinary clinic, pet store, and online retailer channels.

Q5. Who are the key cat vaccine market companies?

Answer: Some of the key cat vaccine companies are as follows:

  • Elanco Animal Health
  • Boehringer Ingelheim
  • Merck
  • Zoetis
  • Bioveta

Q6. Which cat vaccine market segment will be the largest in future?

Answer: Lucintel forecasts that attenuated live will remain the largest segment due to its high efficiency and helps for both antibody and cellular immune responses.

Q7. In cat vaccine market, which region is expected to be the largest in next 5 years?

Answer: North America will remain the largest region due to strict government regulations regarding vaccination in protecting the cats from serious diseases and rising adoption of cats in the USA.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the cat vaccine market by technology (attenuated live vaccines, conjugate vaccines, inactivated vaccines, subunit vaccines, toxoid vaccines, DNA vaccines, and recombinant vaccines), age (below 6 months and above 6 months), distribution channel (veterinary clinics, pet stores, and online retailers), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Cat Vaccine Market : Market Dynamics

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

  • 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
  • 3.2. Global Cat Vaccine Market Trends (2018-2023) and Forecast (2024-2030)
  • 3.3: Global Cat Vaccine Market by Technology
    • 3.3.1: Attenuated Live Vaccines
    • 3.3.2: Conjugate Vaccines
    • 3.3.3: Inactivated Vaccines
    • 3.3.4: Subunit Vaccines
    • 3.3.5: Toxoid Vaccines
    • 3.3.6: DNA Vaccines
    • 3.3.7: Recombinant Vaccines
  • 3.4: Global Cat Vaccine Market by Age
    • 3.4.1: Below 6 Months
    • 3.4.2: Above 6 Months
  • 3.5: Global Cat Vaccine Market by Distribution Channel
    • 3.5.1: Veterinary Clinics
    • 3.5.2: Pet Stores
    • 3.5.3: Online Retailers

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

  • 4.1: Global Cat Vaccine Market by Region
  • 4.2: North American Cat Vaccine Market
    • 4.2.2: North American Cat Vaccine Market by Distribution Channel: Veterinary Clinics, Pet Stores, and Online Retailers
  • 4.3: European Cat Vaccine Market
    • 4.3.1: European Cat Vaccine Market by Technology: Attenuated Live Vaccines, Conjugate Vaccines, Inactivated Vaccines, Subunit Vaccines, Toxoid Vaccines, DNA Vaccines, and Recombinant Vaccines
    • 4.3.2: European Cat Vaccine Market by Distribution Channel: Veterinary Clinics, Pet Stores, and Online Retailers
  • 4.4: APAC Cat Vaccine Market
    • 4.4.1: APAC Cat Vaccine Market by Technology: Attenuated Live Vaccines, Conjugate Vaccines, Inactivated Vaccines, Subunit Vaccines, Toxoid Vaccines, DNA Vaccines, and Recombinant Vaccines
    • 4.4.2: APAC Cat Vaccine Market by Distribution Channel: Veterinary Clinics, Pet Stores, and Online Retailers
  • 4.5: ROW Cat Vaccine Market
    • 4.5.1: ROW Cat Vaccine Market by Technology: Attenuated Live Vaccines, Conjugate Vaccines, Inactivated Vaccines, Subunit Vaccines, Toxoid Vaccines, DNA Vaccines, and Recombinant Vaccines
    • 4.5.2: ROW Cat Vaccine Market by Distribution Channel: Veterinary Clinics, Pet Stores, and Online Retailers

5. Competitor Analysis

  • 5.1: Product Portfolio Analysis
  • 5.2: Operational Integration
  • 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

  • 6.1: Growth Opportunity Analysis
    • 6.1.1: Growth Opportunities for the Global Cat Vaccine Market by Technology
    • 6.1.2: Growth Opportunities for the Global Cat Vaccine Market by Age
    • 6.1.3: Growth Opportunities for the Global Cat Vaccine Market by Distribution Channel
    • 6.1.4: Growth Opportunities for the Global Cat Vaccine Market by Region
  • 6.2: Emerging Trends in the Global Cat Vaccine Market
  • 6.3: Strategic Analysis
    • 6.3.1: New Product Development
    • 6.3.2: Capacity Expansion of the Global Cat Vaccine Market
    • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Cat Vaccine Market
    • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

  • 7.1: Elanco Animal Health
  • 7.2: Boehringer Ingelheim
  • 7.3: Merck
  • 7.4: Zoetis
  • 7.5: Bioveta